Dynamic Capital Management Ltd bought a new position in shares of Bausch Health Companies Inc (NYSE:BHC) in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 8,382 shares of the company’s stock, valued at approximately $207,000.
Other hedge funds have also recently added to or reduced their stakes in the company. FIL Ltd boosted its stake in Bausch Health Companies by 69.6% in the first quarter. FIL Ltd now owns 10,545,300 shares of the company’s stock valued at $260,170,000 after acquiring an additional 4,327,851 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Bausch Health Companies by 0.9% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 8,452,664 shares of the company’s stock worth $156,267,000 after buying an additional 75,175 shares during the last quarter. Bank of Montreal Can grew its holdings in shares of Bausch Health Companies by 28.2% during the 1st quarter. Bank of Montreal Can now owns 3,702,077 shares of the company’s stock valued at $91,441,000 after purchasing an additional 815,311 shares during the last quarter. Orbimed Advisors LLC grew its holdings in shares of Bausch Health Companies by 89.1% during the 4th quarter. Orbimed Advisors LLC now owns 3,600,300 shares of the company’s stock valued at $66,498,000 after purchasing an additional 1,696,400 shares during the last quarter. Finally, Norges Bank bought a new stake in Bausch Health Companies in the 4th quarter worth $59,054,000. Hedge funds and other institutional investors own 53.67% of the company’s stock.
NYSE BHC opened at $21.61 on Thursday. The company has a current ratio of 1.08, a quick ratio of 0.83 and a debt-to-equity ratio of 8.61. The stock has a market capitalization of $7.79 billion, a PE ratio of 5.38, a P/E/G ratio of 0.50 and a beta of 0.61. Bausch Health Companies Inc has a 12 month low of $17.20 and a 12 month high of $28.45.
BHC has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Bausch Health Companies from a “hold” rating to a “buy” rating and set a $28.00 price target for the company in a research report on Thursday, February 14th. Wells Fargo & Co upped their price target on shares of Bausch Health Companies from $9.00 to $25.19 and gave the company an “underperform” rating in a research note on Tuesday, February 19th. HC Wainwright reiterated a “buy” rating on shares of Bausch Health Companies in a research report on Thursday, February 28th. Mizuho boosted their price objective on shares of Bausch Health Companies from $39.00 to $41.00 and gave the company a “buy” rating in a research report on Monday, March 18th. Finally, SunTrust Banks started coverage on shares of Bausch Health Companies in a research report on Tuesday, March 19th. They set a “buy” rating and a $30.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, four have given a hold rating and ten have given a buy rating to the company. Bausch Health Companies currently has an average rating of “Hold” and a consensus target price of $27.65.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://dakotafinancialnews.com/2019/06/13/8382-shares-in-bausch-health-companies-inc-nysebhc-purchased-by-dynamic-capital-management-ltd.html.
About Bausch Health Companies
Bausch Health Companies Inc develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products.
Featured Article: Channel Trading
Want to see what other hedge funds are holding BHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bausch Health Companies Inc (NYSE:BHC).
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.